Improving health outcomes through SDOH

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

APPLICATIONS ARE OPEN! – Letters of Intent due 9/15/23

Around one fourth of the United States population does not have adequate health literacy.
Health literacy is defined as the ability to obtain, read, understand, and apply healthcare
information

Significant improvement in glycemic control among participants demonstrates the substantial impact that pharmacies partnered with charitable medication distributors such as the Dispensary of Hope can have on individuals with insulin-treated T2D

NABP Associate Executive Director Josh Bolin on DSCSA compliance prior to FDA moving compliance deadline.

Uninsured adults and those in worse health continue to report higher rates of not getting care due to costs

Today’s release of new 2020 Census data provides population counts of nearly 1,500 race and ethnicity groups and American Indian and Alaska Native (AIAN) tribes and villages.

In 2011, the opioid crisis reached astounding levels with over 21,000 deaths adding to the urgency of providing aid to those who most need it

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

There are multiple factors that will impact an individual patient’s choice on how to go about getting their prescription medication. It can be overwhelming to navigate this complex issue.

FDA approves 1 Year delay of Track & Trace requirements

Medication non-adherence has led to at least 100,000 preventable deaths each year and $100 billion annually in preventable healthcare costs in the United States

Patients taking opioid dosages at or above 50 MME/day are twice as likely to overdose compared to those taking 20 MME/day, and the risk further increases as the MME/day increases.

Using Public Health Detailing to Increase Access and Confidence in COVID-19 Vaccines and Reinvest in Disproportionately Impacted NYC Communities Go…

Recent federal legislative and regulatory updates in managed care pharmacy have prioritized topics ranging from expedited access to novel therapeutics to the health disparities and equity concerns affecting patient populations nationwide, but progress on these developments will depend on the impact of the midterm elections